PCM
Peregrine Capital Management Portfolio holdings
AUM
$2.7B
1-Year Est. Return
22.12%
This Fund
S&P 500
1 Year Est. Return
+22.12%
AUM
$2.7B
AUM Growth
-$566M
(-17%)
Holding
327
Top Buys
| 1 | +$27.2M | |
| 2 | +$22.8M | |
| 3 | +$11.1M | |
| 4 |
CSW
CSW Industrials
CSW
|
+$10.3M |
| 5 |
DigitalOcean
DOCN
|
+$9.94M |
Top Sells
| 1 | +$43.4M | |
| 2 | +$32.7M | |
| 3 | +$20.5M | |
| 4 |
Duolingo
DUOL
|
+$16M |
| 5 |
Clearwater Analytics
CWAN
|
+$14.6M |
Sector Composition
| 1 | Technology | 25.4% |
| 2 | Healthcare | 15.54% |
| 3 | Financials | 15.14% |
| 4 | Consumer Discretionary | 13.47% |
| 5 | Industrials | 13.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Valvoline
VVV
$4.3B
| $7.96M | 0.3% |
236,396
-10,554
|
|
||
102
Darling Ingredients
DAR
$9.39B
| $7.88M | 0.29% |
127,347
-44,060
|
|
||
103
Yeti Holdings
YETI
$3.63B
| $7.83M | 0.29% |
214,093
-34,301
|
|
||
104
Atlassian
TEAM
$27.3B
| $7.82M | 0.29% |
114,545
-8,153
|
|
||
105
iRhythm Holdings
IRTC
$3.74B
| $7.77M | 0.29% |
65,875
+9,007
|
|
||
106
Cogent Biosciences
COGT
$5.97B
| $7.77M | 0.29% |
+201,959
|
|
||
107
FTI Consulting
FCN
$4.62B
| $7.63M | 0.28% |
43,165
-1,819
|
|
||
|
GRDN
108
Guardian Pharmacy Services
GRDN
$2.45B
| $7.59M | 0.28% |
201,603
-19,453
|
|
||
109
Astronics
ATRO
$3.12B
| $7.58M | 0.28% |
+113,520
|
|
||
110
Celsius Holdings
CELH
$8.51B
| $7.52M | 0.28% |
211,867
-9,616
|
|
||
111
Chemours
CC
$3.33B
| $7.36M | 0.27% |
334,117
-32,244
|
|
||
112
Arcutis Biotherapeutics
ARQT
$2.68B
| $7.22M | 0.27% |
+306,272
|
|
||
113
Scholar Rock
SRRK
$5.91B
| $7.21M | 0.27% |
146,606
-6,248
|
|
||
114
Life Time Group Holdings
LTH
$7.36B
| $7.15M | 0.27% |
265,266
-11,232
|
|
||
115
Braze
BRZE
$2.89B
| $7.03M | 0.26% |
297,650
+66,133
|
|
||
116
Varonis Systems
VRNS
$3.92B
| $7M | 0.26% |
326,153
+42,786
|
|
||
117
Benchmark Electronics
BHE
$3.03B
| $6.97M | 0.26% |
124,349
-11,960
|
|
||
118
Cytokinetics
CYTK
$10.4B
| $6.83M | 0.25% |
103,626
-4,436
|
|
||
119
AvePoint
AVPT
$2.31B
| $6.8M | 0.25% |
715,125
-30,863
|
|
||
120
Adaptive Biotechnologies
ADPT
$2.42B
| $6.75M | 0.25% |
486,641
+34,139
|
|
||
121
Nutanix
NTNX
$14B
| $6.69M | 0.25% |
176,076
-7,492
|
|
||
122
Edgewise Therapeutics
EWTX
$3.68B
| $6.57M | 0.24% |
+208,672
|
|
||
123
Matador Resources
MTDR
$6.66B
| $6.54M | 0.24% |
+103,473
|
|
||
124
BioLife Solutions
BLFS
$1.22B
| $6.52M | 0.24% |
341,847
-14,496
|
|
||
125
Privia Health
PRVA
$2.71B
| $6.51M | 0.24% |
316,718
-13,594
|
|